Drug: Bevacizumab Injury: Nausea Quarter: 2016Q3
Total Records: 63 Number of Pages: 4
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 124312243 | Bevacizumab | Nausea | ROCHE | 66.00 YR | F | 47 KG | 20160816 | JP |
| 125232283 | BEVACIZUMAB | Nausea | AMGEN | 58.00 YR | F | 0 | 20160802 | GB |
| 125281901 | BEVACIZUMAB | Nausea | JANSSEN | 0.00 | 0 | 20160705 | US | |
| 125404372 | Bevacizumab | Nausea | ROCHE | 66.00 YR | M | 55 KG | 20160808 | US |
| 125483631 | BEVACIZUMAB | Nausea | MERCK | 0.00 | 0 | 20160712 | US | |
| 125620512 | BEVACIZUMAB | Nausea | MERCK | 0.00 | 0 | 20160725 | US | |
| 125653661 | Bevacizumab | Nausea | CELGENE | 0.00 | 0 | 20160718 | US | |
| 125732041 | Bevacizumab | Nausea | ROCHE | 0.00 | 0 | 20160720 | JP | |
| 125799942 | BEVACIZUMAB | Nausea | MERCK | 58.00 YR | F | 0 | 20160801 | GB |
| 126009073 | Bevacizumab | Nausea | ROCHE | 0.00 | 0 | 20160901 | US | |
| 126014301 | Bevacizumab | Nausea | ROCHE | 56.95 YR | F | 60 KG | 20160728 | US |
| 126053151 | Bevacizumab | Nausea | ROCHE | 52.00 YR | F | 0 | 20160729 | DE |
| 126096861 | Bevacizumab | Nausea | ROCHE | 0.00 | 0 | 20160801 | CN | |
| 126099531 | Bevacizumab | Nausea | ROCHE | 0.00 | 0 | 20160801 | US | |
| 126100301 | Bevacizumab | Nausea | ROCHE | 0.00 | F | 0 | 20160801 | RU |
| 126128551 | Bevacizumab | Nausea | ROCHE | 0.00 | 0 | 20160802 | US | |
| 126177612 | Bevacizumab | Nausea | ROCHE | 75.00 YR | F | 80 KG | 20160805 | ES |
| 126204001 | Bevacizumab | Nausea | ROCHE | 0.00 | 0 | 20160803 | JP | |
| 126241631 | Bevacizumab | Nausea | ROCHE | 0.00 | 0 | 20160805 | JP | |
| 126250391 | Bevacizumab | Nausea | ROCHE | 0.00 | F | 0 | 20160805 | US |
Total Records: 63 Number of Pages: 4